The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Open accessAbstract
BACKGROUND: Faecal microbiota transplantation [FMT] has been investigated as a potential treatment for inflammatory bowel disease [IBD]. We thus performed a systematic review and meta-analysis assessing the effectiveness and safety of FMT in IBD. METHODS: A systematic review was conducted until January 2017. Studies were excluded if patients had co-infection or data were pooled across disease subtypes (ulcerative colitis [UC], Crohn's disease [CD], pouchitis). Clinical remission was established as the primary outcome. Pooled effect sizes and 95% confidence intervals were obtained using the random effects model. RESULTS: In all, 53 studies were included [41 in UC, 11 in CD, 4 in pouchitis]. Overall, 36% [201/555] of UC, 50.5% [42/83] of CD, and 21.5% [5/23] of pouchitis patients achieved clinical remission. Among cohort studies, the pooled proportion achieving clinical remission was 33% (95% confidence interval [CI] = 23%-43%] for UC and 52% [95% CI = 31%-72%] for CD, both with moderate risk of heterogeneity. For four RCTs in UC, significant benefit in clinical remission (pooled odds ratios [[P-OR] = 2.89, 95% CI = 1.36-6.13, p = 0.006) with moderate heterogeneity [Cochran's Q, p = 0.188; I2 = 37%] was noted. Sub-analyses suggest remission in UC improved with increased number of FMT infusions and lower gastrointestinal tract administration. Most adverse events were transient gastrointestinal complaints. Microbiota analysis was performed in 24 studies, with many identifying increased diversity and a shift in recipient microbiota profile towards the donor post-FMT. CONCLUSIONS: FMT appears effective in UC remission induction, but long-term durability and safety remain unclear. Additional well-designed controlled studies of FMT in IBD are needed, especially in CD and pouchitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results showed that the rates of clinical remission in UC, CD, and pouchitis were 36, 50.5, and 21.5%, respectively.”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [146]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892
2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group
Furlan, A. D., Pennick, V., Bombardier, C., & van Tulder, M. (2009) · Spine · doi:10.1097/brs.0b013e3181b1c99f · Cited by 1,663
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
Research works printed but not linked: 6
- Borody T Leis S McGrath K . Treatment of chronic constipation and colitis using human probiotic infusions. In: Probiotics, Prebiotics and New Foods Conference; September 2–4, 2001; Rome: Universita Urbaniana.
- 2013, Safety of fecal microbiota transplantation [FMT] in immunocompromised [IC] patients with inflammatory bowel disease [IBD], Am J Gastroenterol, 108, S556
- 2015;, Impact of antibiotic treatment before faecal microbiota transplantation [FMT] in chronic active ulcerative colitis, United European Gastroenterol J, 3, A437
- 2016, Safety and efficacy of fecal microbiota transplant in children with inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 63, S212
- 2016, A randomized, placebo-controlled trial of fecal microbial transplantation for pediatric ulcerative colitis [Pedifetch Trial], J Pediatr Gastroenterol Nutr, 63, S79
- Fecal microbiota transplantation via colonoscopy is safe and effective in active ulcerative colitis. In: Advances in Inflammatory Bowel Diseases
Cited by
Sorted by citations
Items 401–436 of 436
Inflammatory bowel disease: The role of commensal microbiome in immune regulation
Wah‐Suárez, M., Martinez-Vazquez, M. A., & Bosques‐Padilla, F. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.08.001
The gut microbiome in health and disease: Inflammatory bowel diseases
El-Sahhar, S., & Varga‐Weisz, P. (2022) · Advances in ecological research/Advances in Ecological Research · doi:10.1016/bs.aecr.2022.09.005
Research Progress of Gut Microbiota’s Function in Metabolic and Immunological Diseases
孙, 卓. (2022) · Open Journal of Natural Science · doi:10.12677/ojns.2022.106107
Mikrobiota, Präbiotika, Antibiotika und fäkaler Mikrobiota-Transfer
Stallmach, A., Steube, A., & Schauer, A. E. (2023) · Springer eBooks · doi:10.1007/978-3-662-64938-1_3
Fecal microbiota transplantation and ulcerative colitis remission: A meta-analysis
Mirghani, H. O., AlShalawi, A. A., Algabri, M. O., Albalawi, T. S., Albalawi, A. M. F., Albalawi, A. N. S., Alzamhari, O. S. A., Alshahrani, M. M. M., Albalawi, M. A. I., Alquthami, H. H. M., et al. (2022) · Medical Science · doi:10.54905/disssi/v26i130/ms570e2672
Tarmflora og tarmsykdom – en edruelig formaning
Juul, F. E., Hov, J. R., Trøseid, M., Johnsen, P. H., & Valeur, J. (2023) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.23.0121
Shimodaira, Y., Fukuda, S., Okubo, R., Onochi, K., & Iijima, K. (2024) · Cureus · doi:10.7759/cureus.57941
Manual de Medicina Interna Vol. 5
Arrobo, E. C. R., Yapud, A. L. A., Villacreses, A. M. M., Mora, R. D. M., Vélez, K. E. C., Ávila, S. A. S., Carrión, J. L. V., Mendoza, H. N. G., Alencastro, J. A. P., Macías, J. R. P., et al. (2024) · doi:10.56470/978-9942-660-63-3
Kirsch, P. M., Rauch, J. H., Delau, O., Axelrad, J. E., Chang, S., & Shaukat, A. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.07.019
Keskin, E. (2025) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.1589820
Microbiota, Prebiotics, Antibiotics, and Fecal Microbiota Transfer
Schauer, A. E., König, A., Nörenberg, J., Vogler, S., Steube, A., & Stallmach, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-87503-8_16
Goren, I., White, I. R., Barkan, R., & Dotan, I. (2025) · Springer eBooks · doi:10.1007/978-3-031-87503-8_33
Chen, C.-C., & Chiu, C.-H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11760-2.00094-x
Mytych, A., Groszewska, J., Romaniuk, M., Rapior, A., Makowska-Woszczyk, D., Lubomska, K., Jagura, P., Romaniuk, J., Dziedziak, M., & Nosek, Ł. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4160
Yang, M., Wang, S., Han, Y., Wang, Y., Duan, Z., Yang, C., Huo, X., Wang, J., Xu, S., & Zhao, Y. (2025) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2025.100147
RetractedTsou, A. M., Goettel, J. A., Bao, B., Biswas, A., Kang, Y. H., Redhu, N. S., Peng, K., Putzel, G., Saltzman, J. S., Kelly, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16928817
Borgers, J. S. W., Burgers, F. H., Terveer, E. M., van Leerdam, M. E., Korse, C. M., Kessels, R., Flohil, C. C., Blank, C. U., Schumacher, T. N., van Dijk, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603451
Microbiome in Autoimmune Diseases: Present and Future
Kim, H. S., & Lee, Y. A. (2026) · Korean Journal of Medicine · doi:10.3904/kjm.2026.101.1.4
Étude de la méthylation des gènes STAT3, IL2RA et CDH1 dans la maladie de Crohn iléale
Abdalla, S. (2023) · theses.fr (ABES) · doi:10.70675/933404e2z16c4z4b5bz87dfze0af93efba89
Couturier, J. L., Kenner, E., Nicula, M., Chowdhury, F., Surette, M., & Pai, N. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109115
de Alcantara, G. R. R., Delmutti, M., & Besson, J. (2026) · Research Society and Development · doi:10.33448/rsd-v15i5.51090
Liu, S., Tang, D., Kang, M., Tong, S., Chen, S., Wei, W., Lan, Y., Li, B., Han, B., & Li, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116965
The selection of matching donors for patients in fecal microbiota transplantation
Qian, X., Yao, W., Wang, W., Shao, H., & Xu, Z. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1859411
Mucosal barriers and gut microbiota: Traditional concepts and recent advances
Yu, L. C.-H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00003-x
Petitfils, C., & Cénac, N. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.0910
Targeting the Gut with Precision: Microbioreactors in Next-Gen Probiotic Screening
Mishra, N., Bajpai, M., & Sharma, T. (2026) · Springer eBooks · doi:10.1007/978-3-032-22332-6_5
Abdelhadi, L. A. M., Liang, Y., Liao, Y., & Zhu, G. (2026) · Gut Pathogens · doi:10.1186/s13099-026-00852-2
Strain-level ecological filtering governs microbial colonization of the human gut
Baertschi, I., Jordi, S. B. U., Gardaz, L. J., Bigi, F. V., Sokollik, C., Juillerat, P., & Yılmaz, B. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117775
Precision microbiome medicine and therapeutics: the enabling role of in vitro gut models
Huang, Z., Ng, S. C., Sokol, H., & Rolhion, N. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuag038
Liu, S., Han, B., Kang, M., Tong, S., Chen, S., Wei, W., Lan, Y., Li, B., Li, Y., & Tang, D. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179259
Amoroso, C., Strati, F., Maragno, P., Caridi, B., Noviello, D., Gilodi, M., Muià, M., Frazzini, S., Perillo, F., Vecchi, M. L., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106475
Javed, A., Chrysostomou, D., Marchesi, J. R., Roberts, L. A., Hart, A. L., Powell, N., Williams, H. R. T., Hicks, L., Mullish, B. H., & Alexander, J. L. (2026) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izag219
Metadata
- Authors
- Paramsothy, S., Paramsothy, R., Rubin, D. T., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., & Castaño-Rodríguez, N.
- Affiliations
- UNSW Sydney (AU)
- Liverpool Hospital (AU)
- University of Chicago (US)
- The University of Melbourne (AU)
- Venue
- Journal of Crohn s and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-09
- Volume
- 11
- Issue
- 10
- Pages
- 1180-1199
- ISSN
- 1873-9946 (ISSN-L)
- 1876-4479
- OpenAlex
- W2586374101
- Cited by
- 436
- References
- 71
- Citations by year
- 2026: 21 · 2025: 36 · 2024: 41 · 2023: 39 · 2022: 56 · 2021: 56 · 2020: 77 · 2019: 62 · 2018: 40 · 2017: 7
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Crohn s and Colitis (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Institute NSW
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, inflammatory bowel disease
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Colitis, Ulcerative, Crohn Disease, Humans, Inflammatory Bowel Diseases, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
